Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients with Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron Epoch.
The journal of infectious diseases (Online University of Chicago Press)/The Journal of infectious diseases（2022）
关键词
SARS-CoV-2,bebtelovimab,COVID-19,hospitalization,monoclonal antibodies,nirmatrelvir,Paxlovid,ritonavir
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要